SCD and lung adenocarcinoma: Importantly, inhibition of SCD1 overcomes drug resistance of lung adenocarcinoma CSCs to cisplatin [177] and liver TICs to chemotherapeutic drugs [176, 178], making it a desirable approach for novel combined therapeutic strategies.